EDWARDS LIFESCIENCES CORP revenue breakdown overview

EDWARDS LIFESCIENCES CORP revenue for the last year amounted to 101.99 B MXN, the most of which — 69.26 B MXN — came from its highest performing source at the moment, Transcatheter Mitral and Tricuspid Therapies, the year earlier bringing 70.89 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought EDWARDS LIFESCIENCES CORP 59.60 B MXN, and the year before that — 61.10 B MXN.